FLT3 and acute myeloid leukemia: Somatic mutations, such as NPM1, FLT3‐ITD, and TP53, enable hematopoietic stem and progenitor cells to acquire the ability of self‐renewal, which is crucial for the pathogenesis and prognosis of AML.2